Perceptions and opinions regarding human papilloma virus vaccination among young women in Malaysia

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 6, 2010, Pages 1515-1521

  Al Naggar, Redhwan Ahmed ^a   Al Jashamy, Karim ^b   Chen, Robert ^c  

^a MANAGEMENT AND SCIENCE UNIVERSITY   (Malaysia)

^b SEGI UNIVERSITY   (Malaysia)

^c UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

Author keywords

HPV vaccination; Malaysia; Perceptions; Young women

Indexed keywords

EID: 79956074483     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Biro FM, Rosenthal SL, Kollar LM, et al, (1997). Adolescent girl's understanding of Papanicolau smear results. J Pediatr Adolesc Gynecol, 10, 209-12
2. Bosch FX, Manos MM, Munoz N, et al, (1995). Prevalence of Human Papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst, 87, 796-802
3. Brabin L, Roberts SA, Farzaneh F, et al, (2006). Future acceptance of adolescent human papillomavirus vaccination. A survey of parental attitudes. Vaccine, 24, 3087-94
4. Burak LJ and Meyer M (1997). Using the health belief model to examine and predict college women's cervical cancer screening beliefs and behavior. Hlth Care Women Int, 18, 251-62.
5. Chan SS, Cheung TH, Lo WK, et al, (2007). Women's attitudes on human papillomavirus vaccination to their daughters. J Adolesc Hlth, 41, 204-7.
6. Cheah PL (2007). Human papillomavirus related diseases in Malaysians. Malays J Pathol, 16, 15-7.
7. Coombes R (2007). Life saving treatment or giant experiment? BMJ, 334, 721-3.
8. Cutts FT, Franceschi S, Goldie S, et al, (2007). Human papillomavirus and HPV vaccines: a review. Bull WHO 85, 719-26.
9. Davis K, Dickman ED, Ferris D, et al, (2004). Human papillomavirus vaccine acceptability among parents of 10-to 15-year-old adolescents. J Lower Genit Tract Dis, 8, 188-94.
10. Di Giuseppe G, Abbate R, Liguori G, et al, (2008). Human papillomavirus and vaccination: knowledge, attitudes, and behavioral intention in adolescents and young women in Italy. Br J Cancer, 99, 225-9.
11. Dinh TA, Rosenthal SL, Doan ED, et al, (2007). Attitudes of Mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Hlth, 10, 1016.
12. Donders GG, Gabrovska M, Bellen G, et al, (2008). Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet, 277, 291-8.
13. Food and Drug Administration (FDA). United states department of health and human services. Fda licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. US News. June 8, 2006.
14. Gerend MA, Magloire ZF (2008). Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Hlth, 42, 237-42.
15. Giles M, Garland S (2006). A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet Gynaecol, 46, 311-5.
16. Harper DM, Franco EL, Wheeler C, et al, (2004). Efficacy of bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet, 364, 1757-65.
17. Harper DM, Franco EL, Wheeler C, et al, (2006) Sustained efficacy up to 4.5 years of bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized controlled trial. Lancet, 367, 1247-55.
18. Hoover DR, Carfioli B, Moench EA (2000). Attitudes of adolescent/young women toward human papillomavirus vaccination and clinical trials. Hlth Care Women Int, 21, 375-91.
19. Hopenhayn C, Christian A, Christian WJ, et al, (2007). Human papillomavirus vaccine: Knowledge and attitudes in two Appalachian Kentucky countries. Cancer Causes Control, 18, 627-34.
20. Horn JE, McQuillan GM, Ray PA, et al, (1990). Reproductive health practices in women attending an inner city STD clinic. Sex Transm Dis, 17, 133-7.
21. Kahn JA, Rosenthal SL, Hamann T, et al, (2003). Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS, 14, 300-6.
22. Koutsky LA, Ault KA, Wheeler CM, et al, (2002). A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med, 347, 1645-51.
23. Lee PW, Kwan TT, Tam KF, et al, (2007). Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong. Prev Med, 345, 130-4.
24. Lehtinen M, Apter D, Dubin G, et al, (2006). Enrolment of 22,000 adolescent women to cancer registry follow up for long term human papillomavirus vaccine efficacy: guarding against guesses. Int J STD AIDS, 17, 517-21.
25. Lenselink CH, Schmeink CE, Melchers WJG, et al, (2008). Young adults and acceptance of the human papillomavirus vaccine. Public Hlth, 122, 1295-301.
26. Lowndes CM, Gill OM (2005). Cervical cancer, human papilloma virus and vaccination. BMJ, 331, 915-6.
27. Markowitz LE, Dunne EF, Saraiya M, et al, (2007). Centers for disease control and prevention (cdc); advisory committee on immunization practices (acip). Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (acip). MMWR Recomm Rep, 56, 1-26.
28. Marlow LAV, Waller J, Wardle J (2007). Public awareness that HPV is a risk factor for cervical cancer. Br J Cancer, 97, 691-4.
29. Marshall H, Ryan P, Roberton D, et al, (2007). A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Aust N Z J Public Hlth, 31, 235-42.
30. Masad L, Meyer P, Hobbs J (1997). Knowledge of cervical cancer screening among women attending urban colposcopy clinics. Cancer Detect Prev, 21, 103-9.
31. McClelland A, Liamputtong P (2006). Knowledge and acceptance of human papillomavirus vaccination: perspectives of young australians living in melbourne, Australia. Sex Hlth, 3, 95-101.
32. Moreira Jr ED, Oliveira BG, Ferraz FM, et al, (2006). Knowledge and attitudes about human papillomavirus, pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer, 16, 599-603.
33. Munoz N, Castellsague X, de Gonzalez AB, et al, (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine, 24, 1-10.
34. Najem GR, Batuman F, Smith AM (1996). Papanicolau testing among inner-city adolescent girls. Am J Prev Med, 12, 482-6.
35. Parkin DM, Bray F, Ferlay J (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
36. Peckham, pinedo, veronesi: Oxford textbook of oncology. Sections 8-20 volume 2. Oxford: oxford university press, 1995.
37. Poland GA, Jacobson RM, Koutsky LA, et al, (2005). Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial. Mayo Clin Proc, 80, 601-10.
38. Ramirez JE, Ramos DM, Clayton L, et al, (1997). Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Women Hlth, 6, 113-21.
39. Vail-Smith K, White DM (1992). Risk level, knowledge, and preventive behavior for human papillomaviruses among sexually active college women. J Am Coll Hlth, 40, 227-30.
40. Vanslyke JG, Baum J, Plaza V, et al, (2008). HPV and cervical cancer testing and prevention: Knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res, 18, 584-96.
41. Villa LL, Costa RL, Petta CA, et al, (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus- like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271-8.
42. Walboomers JM, Jacobs MV, Manos MM, et al, (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
43. Waller J, McCaffery K, Wardle J (2004) Beliefs about the risk factors for cervical cancer in a British population sample. Prev Med, 38, 745-53.
44. Walsh CD, Gera A, Shah M, et al, (2008). Public knowledge and attitudes towards human papilloma virus (HPV) vaccination. BMC Public Hlth, 8, 368.
45. Wong LP (2010). Role of men in promoting the uptake of HPV vaccinations: Focus groups' finding from a developing country. Int J Public Hlth, 55, 35-42.
46. Zimet GD, Mays RM, Winston Y, et al, (2000). Acceptability of human papillomavirus immunization. J Womens Hlth Gend Based Med, 9, 47-50.